IMVT SG&A Expense Growth
Immunovant Inc · SG&A Expense Growth
IMVT SG&A Expense Growth
Latest reported-1.29%period ending
IMVT FY SG&A Growth (YoY) (0.00% → -1.29%)
Latest values, visible window
High-resolution chart · PNG
IMVT sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -1.2857% | |
| 34.8353% | |
| 19.2882% | |
| -11.4449% | |
| 37.2333% | |
| 236.8542% | |
| 2,618,203.5714% | |
| -99.9697% | |
| 0% |